Concepedia

Linda Saf Eldin

LS

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2022

Affiliations

Sinocelltech Group (China)(Current)

Dubai Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Linda Saf Eldin is an author at Sinocelltech Group (China).

Publications per year

2022–2023

3

Publications

3

Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial

Suad Hannawi, Linda Saf Eldin, Alaa Abuquta et al. · EBioMedicine · 2022 · 28 citations · Full text

Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial

Suad Hannawi, Lixin Yan, Linda Saf Eldin et al. · EClinicalMedicine · 2023 · 25 citations · Full text

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Suad Hannawi, Linda Saf Eldin, Alaa Abuquta et al. · Nature Communications · 2023 · 19 citations · Full text

1–3 of 3